US · MTVA
MetaVia Inc.
Price · as of 2026-09-04
$1.75
Market cap 3.28M
Price history
| Week | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2024 – Nov 8, 2024 | $27.50 | $32.89 | $26.51 | $30.80 | 0 |
| Nov 11, 2024 – Nov 15, 2024 | $32.45 | $32.45 | $23.98 | $24.42 | 0 |
| Nov 18, 2024 – Nov 22, 2024 | $25.41 | $27.50 | $24.75 | $26.07 | 0 |
| Nov 25, 2024 – Nov 29, 2024 | $27.50 | $29.15 | $25.30 | $28.05 | 0 |
| Dec 2, 2024 – Dec 6, 2024 | $25.63 | $29.15 | $22.44 | $25.41 | 0 |
| Dec 9, 2024 – Dec 13, 2024 | $24.64 | $27.50 | $23.98 | $24.09 | 0 |
| Dec 16, 2024 – Dec 20, 2024 | $25.30 | $27.50 | $17.05 | $17.60 | 0 |
| Dec 23, 2024 – Dec 27, 2024 | $18.26 | $21.23 | $16.61 | $19.36 | 0 |
| Dec 30, 2024 – Jan 3, 2025 | $20.68 | $24.09 | $19.36 | $23.54 | 0 |
| Jan 6, 2025 – Jan 10, 2025 | $24.42 | $30.25 | $22.00 | $22.66 | 0 |
| Jan 13, 2025 – Jan 17, 2025 | $23.65 | $23.87 | $20.46 | $21.45 | 0 |
| Jan 20, 2025 – Jan 24, 2025 | $21.01 | $22.00 | $19.91 | $21.12 | 0 |
| Jan 27, 2025 – Jan 31, 2025 | $21.45 | $23.54 | $19.25 | $19.91 | 0 |
| Feb 3, 2025 – Feb 7, 2025 | $19.14 | $20.57 | $18.70 | $19.03 | 0 |
| Feb 10, 2025 – Feb 14, 2025 | $19.58 | $21.34 | $17.82 | $18.37 | 0 |
| Feb 17, 2025 – Feb 21, 2025 | $18.26 | $19.47 | $16.61 | $17.60 | 0 |
| Feb 24, 2025 – Feb 28, 2025 | $18.04 | $18.37 | $14.19 | $16.06 | 0 |
| Mar 3, 2025 – Mar 7, 2025 | $16.06 | $18.48 | $15.18 | $17.05 | 0 |
| Mar 10, 2025 – Mar 14, 2025 | $17.05 | $18.26 | $15.51 | $16.28 | 0 |
| Mar 17, 2025 – Mar 21, 2025 | $17.16 | $18.04 | $16.28 | $17.05 | 0 |
| Mar 24, 2025 – Mar 28, 2025 | $16.83 | $17.93 | $16.61 | $17.38 | 0 |
| Mar 31, 2025 – Apr 4, 2025 | $16.72 | $18.15 | $15.62 | $16.06 | 0 |
| Apr 7, 2025 – Apr 11, 2025 | $15.62 | $16.83 | $13.86 | $15.95 | 0 |
| Apr 14, 2025 – Apr 17, 2025 | $15.95 | $23.10 | $7.12 | $8.13 | 0 |
| Apr 21, 2025 – Apr 25, 2025 | $8.02 | $9.46 | $7.37 | $9.05 | 0 |
| Apr 28, 2025 – May 2, 2025 | $9.13 | $9.13 | $8.08 | $8.57 | 0 |
| May 5, 2025 – May 9, 2025 | $8.35 | $8.80 | $7.26 | $8.02 | 0 |
| May 12, 2025 – May 16, 2025 | $7.93 | $8.06 | $7.15 | $7.53 | 0 |
| May 19, 2025 – May 23, 2025 | $7.48 | $9.63 | $7.35 | $8.69 | 0 |
| May 26, 2025 – May 30, 2025 | $8.58 | $8.86 | $6.96 | $7.15 | 0 |
| Jun 2, 2025 – Jun 6, 2025 | $7.40 | $7.84 | $7.15 | $7.61 | 0 |
| Jun 9, 2025 – Jun 13, 2025 | $7.72 | $8.80 | $7.61 | $8.05 | 0 |
| Jun 16, 2025 – Jun 20, 2025 | $8.14 | $8.32 | $7.44 | $7.44 | 0 |
| Jun 23, 2025 – Jun 27, 2025 | $7.41 | $7.80 | $6.93 | $6.93 | 0 |
| Jun 30, 2025 – Jul 3, 2025 | $7.16 | $7.43 | $6.88 | $7.13 | 0 |
| Jul 7, 2025 – Jul 11, 2025 | $7.13 | $8.14 | $6.62 | $7.90 | 0 |
| Jul 14, 2025 – Jul 18, 2025 | $7.87 | $7.97 | $7.21 | $7.41 | 0 |
| Jul 21, 2025 – Jul 25, 2025 | $7.70 | $8.20 | $7.32 | $7.76 | 0 |
| Jul 28, 2025 – Aug 1, 2025 | $7.70 | $7.78 | $6.60 | $6.70 | 0 |
| Aug 4, 2025 – Aug 8, 2025 | $7.08 | $7.27 | $6.11 | $6.93 | 0 |
| Aug 11, 2025 – Aug 15, 2025 | $7.16 | $7.30 | $6.71 | $7.04 | 0 |
| Aug 18, 2025 – Aug 22, 2025 | $7.04 | $7.26 | $6.67 | $7.15 | 0 |
| Aug 25, 2025 – Aug 29, 2025 | $7.10 | $7.24 | $6.80 | $6.98 | 0 |
| Sep 1, 2025 – Sep 5, 2025 | $6.82 | $7.70 | $6.82 | $7.59 | 0 |
| Sep 8, 2025 – Sep 12, 2025 | $7.81 | $7.81 | $7.27 | $7.66 | 0 |
| Sep 15, 2025 – Sep 19, 2025 | $7.56 | $19.03 | $7.50 | $11.44 | 0 |
| Sep 22, 2025 – Sep 26, 2025 | $10.67 | $12.10 | $10.45 | $10.67 | 0 |
| Sep 29, 2025 – Oct 3, 2025 | $10.67 | $11.44 | $9.91 | $11.33 | 0 |
| Oct 6, 2025 – Oct 10, 2025 | $11.55 | $12.87 | $10.56 | $10.76 | 0 |
| Oct 13, 2025 – Oct 17, 2025 | $11.22 | $12.21 | $9.90 | $10.70 | 0 |
| Oct 20, 2025 – Oct 24, 2025 | $10.84 | $11.44 | $10.37 | $10.78 | 0 |
| Oct 27, 2025 – Oct 31, 2025 | $10.78 | $11.11 | $10.45 | $10.92 | 0 |
| Nov 3, 2025 – Nov 7, 2025 | $10.89 | $14.85 | $8.28 | $9.99 | 0 |
| Nov 10, 2025 – Nov 14, 2025 | $9.24 | $9.24 | $6.82 | $7.69 | 0 |
| Nov 17, 2025 – Nov 21, 2025 | $7.92 | $9.30 | $7.28 | $7.64 | 0 |
| Nov 24, 2025 – Nov 28, 2025 | $7.59 | $8.79 | $7.59 | $8.56 | 0 |
| Dec 1, 2025 – Dec 5, 2025 | $8.53 | $8.58 | $6.05 | $8.18 | 0 |
| Dec 8, 2025 – Dec 12, 2025 | $10.27 | $13.42 | $8.01 | $9.31 | 0 |
| Dec 15, 2025 – Dec 19, 2025 | $9.37 | $9.37 | $7.81 | $8.62 | 0 |
| Dec 22, 2025 – Dec 26, 2025 | $8.62 | $10.00 | $8.40 | $9.19 | 0 |
| Dec 29, 2025 – Jan 2, 2026 | $9.19 | $9.56 | $8.01 | $9.56 | 0 |
| Jan 5, 2026 – Jan 9, 2026 | $9.61 | $9.61 | $8.01 | $8.15 | 0 |
| Jan 12, 2026 – Jan 16, 2026 | $8.17 | $8.31 | $2.95 | $3.11 | 0 |
| Jan 19, 2026 – Jan 23, 2026 | $3.10 | $3.14 | $2.74 | $2.83 | 0 |
| Jan 26, 2026 – Jan 30, 2026 | $2.90 | $2.90 | $2.32 | $2.43 | 0 |
| Feb 2, 2026 – Feb 6, 2026 | $2.58 | $2.87 | $1.66 | $1.82 | 0 |
| Feb 9, 2026 – Feb 13, 2026 | $1.84 | $1.96 | $1.54 | $1.64 | 0 |
| Feb 16, 2026 – Feb 20, 2026 | $1.64 | $1.72 | $1.43 | $1.55 | 0 |
| Feb 23, 2026 – Feb 27, 2026 | $1.58 | $1.73 | $1.50 | $1.51 | 0 |
| Mar 2, 2026 – Mar 6, 2026 | $1.51 | $1.68 | $1.50 | $1.55 | 0 |
| Mar 9, 2026 – Mar 13, 2026 | $1.56 | $1.68 | $1.34 | $1.61 | 0 |
| Mar 16, 2026 – Mar 20, 2026 | $1.62 | $1.64 | $1.36 | $1.41 | 0 |
| Mar 23, 2026 – Mar 27, 2026 | $1.49 | $1.55 | $1.21 | $1.22 | 0 |
| Mar 30, 2026 – Apr 2, 2026 | $1.22 | $1.29 | $1.17 | $1.26 | 0 |
| Apr 6, 2026 – Apr 10, 2026 | $1.27 | $1.46 | $1.17 | $1.41 | 0 |
| Apr 13, 2026 – Apr 17, 2026 | $1.50 | $1.60 | $1.36 | $1.40 | 0 |
| Apr 20, 2026 – Apr 24, 2026 | $1.40 | $1.67 | $1.38 | $1.56 | 0 |
| Apr 27, 2026 – May 1, 2026 | $1.58 | $1.67 | $1.41 | $1.44 | 0 |
| May 4, 2026 – May 8, 2026 | $1.43 | $1.54 | $1.00 | $1.09 | 0 |
| May 11, 2026 – May 15, 2026 | $1.19 | $1.24 | $0.97 | $1.11 | 0 |
| May 18, 2026 – May 22, 2026 | $1.10 | $4.31 | $1.08 | $3.85 | 0 |
| May 25, 2026 – May 29, 2026 | $3.35 | $3.80 | $2.73 | $2.84 | 0 |
| Jun 1, 2026 – Jun 5, 2026 | $2.73 | $2.96 | $2.32 | $2.57 | 0 |
| Jun 8, 2026 – Jun 12, 2026 | $2.21 | $2.41 | $1.70 | $1.74 | 0 |
| Jun 15, 2026 – Jun 18, 2026 | $1.70 | $1.92 | $1.57 | $1.60 | 0 |
| Jun 22, 2026 – Jun 26, 2026 | $1.60 | $1.66 | $1.41 | $1.43 | 0 |
| Jun 29, 2026 – Jul 2, 2026 | $1.43 | $1.56 | $1.38 | $1.48 | 0 |
| Jul 6, 2026 – Jul 10, 2026 | $1.41 | $1.80 | $1.41 | $1.78 | 0 |
| Jul 13, 2026 – Jul 17, 2026 | $1.76 | $2.61 | $1.68 | $1.71 | 0 |
| Jul 20, 2026 – Jul 24, 2026 | $1.76 | $1.76 | $1.42 | $1.48 | 0 |
| Jul 27, 2026 – Jul 31, 2026 | $1.49 | $1.52 | $1.38 | $1.42 | 0 |
| Aug 3, 2026 – Aug 7, 2026 | $1.48 | $1.56 | $1.43 | $1.49 | 0 |
| Aug 10, 2026 – Aug 14, 2026 | $1.44 | $1.52 | $1.42 | $1.49 | 0 |
| Aug 17, 2026 – Aug 21, 2026 | $1.50 | $1.54 | $1.43 | $1.46 | 0 |
| Aug 24, 2026 – Aug 28, 2026 | $1.44 | $1.80 | $1.44 | $1.70 | 0 |
| Aug 31, 2026 – Sep 4, 2026 | $1.70 | $1.93 | $1.65 | $1.75 | 0 |
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | -0.22 | |
| P/B | 0.53 | |
| P/S | — | |
| EV/EBITDA | 0.56 | |
| PEG | — | |
| P/TBV | 0.53 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | $605,220.00 | ||||
| 2017 | $508,860.00 | ||||
| 2018 | $84,480.00 | ||||
| 2019 | $43,507.20 | ||||
| 2020 | $11,695.20 | ||||
| 2021 | $1,995.84 | ||||
| 2022 | $63.62 | ||||
| 2023 | $58.96 | ||||
| 2024 | $17.05 | ||||
| 2025 | $1.61 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About MetaVia Inc.
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
- CEO
- Hyung Heon Kim
- Employees
- 8
- Beta
- 0.97
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MTVA | MetaVia Inc. | $1.49 | 3.28M | — | — | -0.22 | 0.53 | — | 0.56 | — | 0.53 | 0.00% | 0.00% | 0.00% | -195.61% | 216.13% | -30.39% | 0.04 | — | 1.93 | 1.82 | 0.78 | -81.23% | — | -36.47% | -552.28% | -2.78 | 247.58% | 0.00% | 0.00% | 0.00% | 0.53 | 0.46 | — | -3.55 |
| CLGN | CollPlant Biotechnologies… | $0.34 | 4.39M | $35.20 | +10,288% | -0.62 | 1.17 | 3.01 | -0.38 | — | 1.19 | 26.32% | -484.31% | -484.56% | -117.56% | -301.63% | -77.90% | 0.47 | -765.53 | 2.53 | 2.23 | 0.29 | -35.17% | 360.39% | -35.19% | -132.33% | -3.53 | -248.15% | 0.00% | 0.00% | 0.00% | -0.35 | -0.43 | 1.70 | -18.14 |
| ENLV | Enlivex Therapeutics Ltd. | $2.08 | 35.01M | — | — | 0.04 | 0.02 | — | -2.88 | — | 0.04 | 0.00% | 0.00% | 0.00% | 126.17% | -1.19% | 104.94% | 0.00 | -1153.85 | 193.24 | 0.68 | 0.09 | -3590.41% | — | -20.04% | -22.06% | -1.15 | -1.09% | 0.00% | 0.00% | 0.00% | -2.82 | -4.03 | — | 1.61 |
| LSTA | Lisata Therapeutics, Inc. | $1.06 | 9.65M | $15.41 | +1,354% | -2.63 | 2.94 | 257.03 | -1.59 | — | 2.94 | 14.12% | -10711.18% | -9756.47% | -74.67% | 1304.83% | -62.89% | 0.00 | — | 5.76 | 5.42 | 0.92 | -20.42% | -83.00% | -17.46% | -36.56% | -5.19 | 1211.30% | 0.00% | 0.00% | 0.00% | -1.52 | -1.74 | 163.17 | -38.60 |
| NCNA | NuCana plc | $1.47 | 8.93M | — | — | -0.18 | 0.22 | — | 0.89 | -0.13 | 0.24 | 0.00% | 0.00% | 0.00% | -193.87% | -26313.49% | -131.60% | 0.03 | — | 5.60 | 5.58 | 1.15 | 137.00% | — | -60.54% | -146.37% | -1.56 | -10421.77% | 0.00% | 0.00% | 325.15% | 0.91 | 2.39 | — | -12.61 |
| PASG | Passage Bio, Inc. | $4.40 | 14.14M | — | — | -0.52 | 1.26 | — | -0.03 | — | 1.26 | 0.00% | 0.00% | 0.00% | -113.78% | -1339.47% | -55.28% | 1.28 | — | 2.07 | 2.01 | 0.50 | -33.07% | — | -34.34% | -133.30% | -1.37 | -978.08% | 0.00% | 0.00% | 43.13% | -0.03 | -0.04 | — | -17.33 |
| XCUR | Exicure, Inc. | $1.35 | 8.57M | $4.64 | +245% | -5.35 | 6.74 | — | -4.47 | — | -6.21 | 0.00% | 0.00% | 0.00% | -92.47% | -3231.53% | -34.00% | 0.04 | -10117.00 | 1.19 | 0.98 | 0.70 | -50.31% | -100.00% | 194.02% | -32.35% | -2.20 | -3083.24% | 0.00% | 0.00% | 0.00% | -2.26 | -2.67 | — | -21.11 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $1.75) − 1 = — (IC, example).